John L. Marshall

Active 1969–2025

139
Papers
22,291
Citations
84
h-index
135
i10-index

Citations

Citations per year for John L. Marshall1973: 2 citations1974: 2 citations1975: 2 citations1976: 3 citations1977: 9 citations1979: 16 citations1980: 11 citations1981: 5 citations1982: 10 citations1983: 15 citations1984: 11 citations1985: 15 citations1986: 16 citations1987: 19 citations1988: 27 citations1989: 41 citations1990: 43 citations1991: 31 citations1992: 34 citations1993: 31 citations1994: 38 citations1995: 28 citations1996: 30 citations1997: 36 citations1998: 28 citations1999: 39 citations2000: 38 citations2001: 46 citations2002: 61 citations2003: 80 citations2004: 103 citations2005: 127 citations2006: 136 citations2007: 133 citations2008: 122 citations2009: 136 citations2010: 141 citations2011: 167 citations2012: 185 citations2013: 176 citations2014: 175 citations2015: 191 citations2016: 181 citations2017: 161 citations2018: 167 citations2019: 519 citations2020: 615 citations2021: 723 citations2022: 583 citations2023: 429 citations2024: 619 citations2025: 320 citations2026: 7 citations1978: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,877 citing papers, 28.9% of this breakdownChina: 1,122 citing papers, 11.3% of this breakdownUnited Kingdom: 748 citing papers, 7.5% of this breakdownItaly: 513 citing papers, 5.2% of this breakdownGermany: 461 citing papers, 4.6% of this breakdownFrance: 338 citing papers, 3.4% of this breakdownJapan: 338 citing papers, 3.4% of this breakdownCanada: 305 citing papers, 3.1% of this breakdownSpain: 263 citing papers, 2.6% of this breakdownNetherlands: 261 citing papers, 2.6% of this breakdownAustralia: 226 citing papers, 2.3% of this breakdownIndia: 170 citing papers, 1.7% of this breakdown
0%28.9%Other 23.4%

Fields

  • Medicine62%
  • Biochemistry, Genetics and Molecular Biology28.6%
  • Immunology and Microbiology4.3%
  • Engineering1.1%
  • Computer Science0.8%
  • Materials Science0.7%
  • Other2.5%

Topics

  • Cancer Genomics and Diagnostics5.3%
  • Cancer Immunotherapy and Biomarkers4.2%
  • Knee injuries and reconstruction techniques4.1%
  • Colorectal Cancer Treatments and Studies3.4%
  • Total Knee Arthroplasty Outcomes3.2%
  • Pancreatic and Hepatic Oncology Research2.5%
  • Other77.3%

Coauthors

All papers

Open in search
  1. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Y. Lewis, Gillian Mackay, Douglas Strathdee, Saverio Tardito, Eyal Gottlieb, Andrew D. Campbell, Arafath K. Najumudeen, Alan M. Race, Ian S. Gilmore, G. McMahon, Paul Grant, Bin Yan, Adam Taylor, Efstathios A. Elia, Spencer A. Thomas, Catherine Munteanu, Ala Al-Afeef, Amy Burton, Jean‐Luc Vorng, Xavier Loizeau, Weiwei Zhou, Ammar Nasif, Ariadna Gonzalez, Hanifa Koquna, Martin Metodiev, Melina Kyriazi, Junting Zhang, Lucas Zeiger, Johan Vande Voorde, Jennifer P. Morton, Dmitry A. Soloviev, Vincen Wu, Yuchen Xiang, Daniel McGill, Stefania Maneta-Stravrakaki, Jaynisha Mistry, Emine Kazanç, Mariia Yuneva, Yulia Panina, Chandan Seth Nanda, Peter Kreuzaler, Avinash Ghanate, Stephanie Ling, Jack Richings, Kevin M. Brindle, Anastasia Tsyben, George Poulogiannis, Amit Gupta, Aurélien Tripp, Evi Karali, Nikos Koundouros, Thanasis Tsalikis, John L. Marshall, Magali Garrett, Harry Hall, Zoltán Takáts, Simon T. Barry, Richard J. A. Goodwin, Josephine Bunch, Martin Bushell, Andrew D. Campbell, Owen J. Sansom - Nature Genetics 2021 cited by 329

  2. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Warren Tom, Enock Teefe, Shann-Ching Chen, Sharmin Begum, Adam Rabinowitz, Benjamin Phillimore, Bradley Spencer‐Dene, Gordon Stamp, Zoltán Szállási, Nik Matthews, Aengus Stewart, Peter J. Campbell, Charles Swanton - Science 2014 cited by 1,170

  3. Prevalence of Homologous Recombination–Related Gene Mutations Across Multiple Cancer Types

    Authors: , , , , , , , , - JCO Precision Oncology 2018 cited by 465

  4. Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients

    Authors: , , , , - Cancer Medicine 2018 cited by 471

  5. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frances R. Balkwill, Simon T. Barry, Robert Grützmann, Lola Rahib, Sarah Allison, Peter J. Bailey, Ulla‐Maja Bailey, Andrew V. Biankin, Dario Beraldi, Holly Brunton, Giuseppina Caligiuri, Euan Cameron, David K. Chang, Susanna L. Cooke, Richard Cunningham, Stephan B. Dreyer, Paul Grimwood, Shane Kelly, Eirini-Maria Lampraki, John L. Marshall, Sancha Martin, Brian McDade, Daniel L. McElroy, Elizabeth A. Musgrove, Craig Nourse, Viola Paulus-Hock, Donna Ramsay, Rosie Upstill-Goddard, Derek Wright, Marc D. Jones, Lisa Evers, Selma Rebus, Lola Rahib, Bryan Serrels, Jane Hair, Nigel B. Jamieson, Colin J. McKay, Paul Westwood, Nicola Williams, Fraser Duthie, Andrew V. Biankin, Amber L. Johns, Amanda Mawson, David K. Chang, Christopher J. Scarlett, Mary-Anne L. Brancato, Sarah J. Rowe, Skye H. Simpson, Mona Martyn-Smith, Michelle T. Thomas, Lorraine A. Chantrill, Venessa Chin, Angela Chou, Mark J. Cowley, Jeremy L. Humphris, Marc D. Jones, R. Scott Mead, Adnan M. Nagrial, Marina Pajic, Jessica Pettit, Mark Pinese, Ilse Rooman, Jianmin Wu, Tao Jiang, Renee DiPietro, Clare Watson, Angela Steinmann, Hong Ching Lee, Rachel Wong, Andreia V. Pinho and 146 more - Gastroenterology 2020 cited by 173

  6. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David A. Tuveson, Pedro A. Pérez–Mancera, Ville Mustonen, Andrej Fischer, David J. Adams, Alistair G. Rust, Waraporn Chan-on, Chutima Subimerb, Karl Dykema, Kyle Furge, Peter J. Campbell, Bin Tean Teh, Michael R. Stratton, P. Andrew Futreal - Nature 2011 cited by 1,291

  7. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susanna L. Cooke, Stephan B. Dreyer, Paul Grimwood, Shane Kelly, John L. Marshall, Brian McDade, Daniel L. McElroy, Donna Ramsay, Rosanna Upstill‐Goddard, Selma Rebus, Jane Hair, Nigel B. Jamieson, Colin J. McKay, Paul Westwood, Nicola Williams, Fraser R. Duthie, Andrew V. Biankin, Amber L. Johns, Amanda Mawson, David K. Chang, Christopher J. Scarlett, Mary-Anne L. Brancato, Sarah J. Rowe, Skye H. Simpson, Mona Martyn-Smith, Michelle T. Thomas, Lorraine A. Chantrill, Venessa Chin, Angela Chou, Mark J. Cowley, Jeremy L. Humphris, R. Scott Mead, Adnan Nagrial, Marina Pajic, Jessica Pettit, Mark Pinese, Ilse Rooman, Jianmin Wu, Tao Jiang, Renee DiPietro, Clare Watson, Angela Steinmann, Hong Ching Lee, Rachel Wong, Andreia V. Pinho, Marc Giry-Laterrière, Roger J. Daly, Elizabeth A. Musgrove, Robert L. Sutherland, Sean M. Grimmond, Nicola Waddell, Karin S. Kassahn, David K. Miller, Peter J. Wilson, Ann-Marie Patch, Sarah Song, Ivon Harliwong, Senel Idrisoglu, Ehsan Nourbakhsh, Suzanne Manning, Shivangi Wani, Milena Gongora, Matthew J. Anderson, Oliver Holmes, Conrad Leonard, Darrin F. Taylor, Scott Wood, Christina Xu, Kátia Nones, J. Lynn Fink and 105 more - Cell Reports 2020 cited by 127

  8. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 cited by 84

  9. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 cited by 435

  10. The current state of molecular testing in the treatment of patients with solid tumors, 2019

    Authors: , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2019 cited by 261

  11. Global mapping of cancers: The Cancer Genome Atlas and beyond

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Oncology 2021 cited by 107

  12. Clinical Validation of a Machine-learning–derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 65

  13. Evaluating the impact of age on immune checkpoint therapy biomarkers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2021 cited by 80

  14. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma

    Authors: , , , , , , , , , - The Oncologist 2018 cited by 193

  15. Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers

    Authors: , , , , , , , , , - Oncotarget 2017 cited by 214

  16. Relationship between MLH1, PMS2, MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors

    Authors: , , , , , , , , , , , , - International Journal of Cancer 2020 cited by 167

  17. Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , - Molecular Therapy 2016 cited by 161

  18. Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 106

  19. The impact of ARID1A mutation on molecular characteristics in colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2020 cited by 75

  20. Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease

    Authors: , , , , , - Journal for ImmunoTherapy of Cancer 2018 cited by 218

  21. A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2008 cited by 852

  22. Colon Cancer in Young Adults: Trends and Their Implications

    Authors: , - Current Oncology Reports 2019 cited by 122

  23. Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 118

  24. Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2021 cited by 78